π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The objectives of this program are to verify the safety and effectiveness o...
Status
Unknown
Location
Clinical Trial Center
Start Date
2014-09
Trial ID
NCT02283502
Treatments Being Tested
A Pivotal Study to Evaluate the Effectiveness and Safety of ArcBlate Pallia...
Status
Unknown
Location
Far Eastern Memorial Hospital
Start Date
2023-12-08
Trial ID
NCT06487013
Treatments Being Tested
The primary purpose of this protocol is to assess the ExAblate 2100 MR guid...
Status
Completed
Location
Stanford Cancer Center
Start Date
2020-11-22
Trial ID
NCT04298242
Treatments Being Tested
An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients w...
Status
Unknown
Location
Far Eastern Memorial Hospital
Start Date
2024-08-01
Trial ID
NCT06487026
Treatments Being Tested
The primary purpose of this protocol is to assess the ExAblate 2100 MR guid...
Status
Withdrawn
Location
Stanford University
Start Date
2014-10
Trial ID
NCT02291978
Treatments Being Tested
The primary objective of this study is to determine whether intra- and post...
Status
Withdrawn
Location
The Royal Marsden NHS Foundation Trust
Start Date
2018-03-16
Trial ID
NCT03479151
Treatments Being Tested
The primary objective of this pilot study is to determine whether or not it...
Status
Completed
Location
The Royal Marsden NHS Foundation Trust
Start Date
2016-05
Trial ID
NCT02714621
Treatments Being Tested
The goal of this proof-of-concept study is to examine the effects of a rela...
Status
Not Yet Recruiting
Location
University of Geneva (UNIGE)
Start Date
2026-05-26
Trial ID
NCT07531238
The goal of this project is to evaluate the safety and preliminary efficacy...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2014-05
Trial ID
NCT01965002
Treatments Being Tested